Laquinimod, CAS [[248281-84-7]]
Artikelnummer:
BYT-ORB1300657
Produktübersicht
Artikelname:
Laquinimod, CAS [[248281-84-7]]
Artikelnummer:
BYT-ORB1300657
Hersteller Artikelnummer:
orb1300657
Alternativnummer:
BYT-ORB1300657-1, BYT-ORB1300657-10, BYT-ORB1300657-100, BYT-ORB1300657-25, BYT-ORB1300657-50, BYT-ORB1300657-500
Hersteller:
Biorbyt
Kategorie:
Biochemikalien
Alternative Synonym:
chronic progressive, Apoptosis, carboxamide, ABR 215062, ABR215062, ABR-215062, Inhibitor, LAQ, Laquinimod, NFkB, neurodegeneration, neurodegenerative disease, Orally, Nuclear factor-kappaB, Nuclear factor-kappaB, NF-kappaB, NFkappaB, NF-kB, multiple sclerosis, inhibit, inflammation, immunomodulator, relapsing remitting
Produktbeschreibung
Laquinimod (LAQ) is an orally administered immunomodulatory small molecule in advanced clinical development for multiple sclerosis. It has demonstrated efficacy in both in vivo experimental autoimmune encephalomyelitis models and in vitro studies targeting immune cell modulation.
Produkteigenschaften
Molekulargewicht:
356.8
Reinheit:
98.84% (May vary between batches)
CAS Nummer:
[248281-84-7]
Formel:
C19H17ClN2O3
Target-Kategorie:
NF-kappaB,Apoptosis
Anwendungsbeschreibung
Anwendungsbeschreibung:
Solubility: 10% DMSO+90% Corn Oil:0.5 mg/mL (1.4 mM),Ethanol:1 mg/mL (2.8 mM),H2O:< 1 mg/mL (insoluble or slightly soluble),DMSO:8 mg/mL (22.42 mM)
